As cited by the research report titled ‘U.S. Cannabis Testing Market Size By Technology, By Test Type (Potency Testing, Pesticide Screening, Residual Solvent Screening, Heavy Metal Testing, Terpene Testing, Mycotoxin Testing), Industry Analysis Report, Zonal Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027’, available with Market Study Report, U.S. cannabis testing market is projected to expand considerably over 2021-2027.
 

Growing usage of cannabis for medical purposes, its increasing legalization across various states, and subsequent rise in the need of ensuring complete consumer safety are the major factors driving the U.S. cannabis testing market growth.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2483988/
 

For the record, testing of cannabis facilitates growers and sellers to meet state regulations by offering high quality, easy to dose products that consumers feel safe for consumption. Cannabis testing requirements usually differ from state to state, although many states need testing and labeling for potency and numerous contaminants like pesticides, heavy metals, microbes, and residual solvents.
 

Trusted sources cite that in Colorado, all cannabis-based products for retail must be tested for various residual solvents before being placed in dispensary shelves. Such regulations set by authorities are strengthening the demand for cannabis testing. Besides, intensive testing by pharma companies as compared to other manufacturers of adult recreational cannabis products is positively affecting the industry demand.
 

Based on technology, the U.S. cannabis testing industry is segmented into chromatography and spectroscopy. The chromatography segment is further divided into gas chromatography, liquid chromatography and others. The spectroscopy segment, classified into mass spectrometry and atomic spectroscopy,  is likely to expand at 10.3% CAGR over the analysis period.
 

Speaking of test type, the marketplace is categorized into potency testing, pesticide screening, heavy metal testing, mycotoxin testing, residual solvent screening, terpene testing, and others. Among these, residual solvent screening segment is anticipated to amass USD 580.1 million over the forecast timeline due to strong testing demand for eliminating residual solvents as they are considered unsafe to health and should not be present in the final product.
 

From a regional frame of reference, North East Zone captured a 10.6% market share in 2020 and is anticipated to showcase similar growth patterns over the forecast timeframe. Likewise, East North Central Zone is likely to grow at 10.6% CAGR during the same time period.
 

Prominent players in the U.S. cannabis testing industry are Steep Hill Inc., SC Laboratories Inc., PSI Labs, Pure Analytical Laboratories LLC, Iron Laboratories LLC, Evio Inc., Digipath Inc., CW Analytical Laboratories Inc., CannaSafe, and Anresco Laboratories Inc.